tiprankstipranks
Advertisement
Advertisement

AU:PYC Stock Latest News

PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
Company AnnouncementsPYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
13d ago
PYC
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
PremiumCompany Announcements
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
13d ago
PYC
PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial
PremiumCompany Announcements
PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial
16d ago
PYC
PYC Therapeutics: Strengthened Balance Sheet and Expanded Development Plan Underpin Continued Buy Rating
PremiumRatings
PYC Therapeutics: Strengthened Balance Sheet and Expanded Development Plan Underpin Continued Buy Rating
19d ago
PYC Therapeutics CEO Increases Shareholding and Awaits Approval for New Options Grant
PremiumCompany Announcements
PYC Therapeutics CEO Increases Shareholding and Awaits Approval for New Options Grant
29d ago
PYC
PYC Therapeutics Seeks ASX Quotation for Over 10.5 Million New Shares
PremiumCompany AnnouncementsPYC Therapeutics Seeks ASX Quotation for Over 10.5 Million New Shares
1M ago
PYC
PYC Therapeutics Seeks ASX Quotation for Over 31 Million New Shares
Premium
Company Announcements
PYC Therapeutics Seeks ASX Quotation for Over 31 Million New Shares
1M ago
PYC
PYC Therapeutics appoints new joint company secretary to oversee ASX compliance
Premium
Company Announcements
PYC Therapeutics appoints new joint company secretary to oversee ASX compliance
1M ago
PYC
PYC Therapeutics Completes $47m Retail Entitlement Offer, Boosting Capital for RNA Programs
PremiumCompany Announcements
PYC Therapeutics Completes $47m Retail Entitlement Offer, Boosting Capital for RNA Programs
1M ago
PYC
PYC Therapeutics Issues Cautious Q1 2026 Investor Update
PremiumCompany Announcements
PYC Therapeutics Issues Cautious Q1 2026 Investor Update
1M ago
PYC
PYC Therapeutics Files Interim Results as RNA Pipeline Advances
PremiumCompany Announcements
PYC Therapeutics Files Interim Results as RNA Pipeline Advances
1M ago
PYC
PYC Therapeutics Seeks ASX Quotation for 354.8 Million New Shares
PremiumCompany Announcements
PYC Therapeutics Seeks ASX Quotation for 354.8 Million New Shares
2M ago
PYC
PYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline
PremiumCompany AnnouncementsPYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline
2M ago
PYC
PYC Therapeutics launches major entitlement offer and placement to fund RNA therapy programs
Premium
Company Announcements
PYC Therapeutics launches major entitlement offer and placement to fund RNA therapy programs
2M ago
PYC
PYC Therapeutics Opens Retail Component of Entitlement Offer to Fund RNA Therapy Pipeline
Premium
Company Announcements
PYC Therapeutics Opens Retail Component of Entitlement Offer to Fund RNA Therapy Pipeline
2M ago
PYC
PYC Therapeutics Sets Investor Webinar to Detail Capital Raise and Pipeline Progress
PremiumCompany Announcements
PYC Therapeutics Sets Investor Webinar to Detail Capital Raise and Pipeline Progress
2M ago
PYC
PYC Therapeutics Secures A$537m in Institutional Raising, Extends Cash Runway to 2030
PremiumCompany Announcements
PYC Therapeutics Secures A$537m in Institutional Raising, Extends Cash Runway to 2030
2M ago
PYC
PYC Therapeutics Launches Major Equity Raising via Entitlement Offer and Placement
PremiumCompany Announcements
PYC Therapeutics Launches Major Equity Raising via Entitlement Offer and Placement
2M ago
PYC
PYC Therapeutics Launches Pro-Rata Entitlement Offer With Limited Control Impact
PremiumCompany Announcements
PYC Therapeutics Launches Pro-Rata Entitlement Offer With Limited Control Impact
2M ago
PYC
PYC Therapeutics Launches Equity Raising via Entitlement Offer and Institutional Placement
PremiumCompany AnnouncementsPYC Therapeutics Launches Equity Raising via Entitlement Offer and Institutional Placement
2M ago
PYC
PYC Therapeutics to Raise Up to A$653m to Advance Four Genetic Disease Drugs
Premium
Company Announcements
PYC Therapeutics to Raise Up to A$653m to Advance Four Genetic Disease Drugs
2M ago
PYC
PYC Therapeutics Requests Trading Halt Ahead of Capital Raising
Premium
Company Announcements
PYC Therapeutics Requests Trading Halt Ahead of Capital Raising
2M ago
PYC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >